Supernus Pharmaceuticals Inc. trailing returns
Supernus Pharmaceuticals Inc.'s 10-year return is +7.0% a year (CAGR) (+97.5% cumulative). How Supernus Pharmaceuticals Inc. (SUPN) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +3.5% | +0.0% | +3.5% | — |
| 5 days | -1.9% | +0.0% | -1.9% | -9.8%Oct 16 |
| 1 month | -1.8% | +0.0% | -1.8% | -15.1%Oct 16 |
| YTD | -17.0% | +0.0% | -17.0% | -32.7%Oct 16 |
| 1 year | -20.1% | +0.0% | -20.1% | -33.5%Oct 2026 |
| 5 years | +6.6% | +0.0% | +6.6%+37.9% | -45.9%Oct 2023 |
| 10 years | +7.0% | +0.0% | +7.0%+97.5% | -75.9%Mar 2020 |
| Since inception (2012) | +15.1% | +0.0% | +15.1%+667.8% | -75.9%Mar 2020 |
Growth of SUPN#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+6.6%/year · +37.9%
- 10 years+7.0%/year · +97.5%
- Since inception (2012)+15.1%/year · +667.8%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in SUPN's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Supernus Pharmaceuticals Inc.'s 10-year return?
- Over the last 10 years, Supernus Pharmaceuticals Inc. (SUPN) returned about +7.0% a year annualized (+97.5% cumulative total return).
- What is Supernus Pharmaceuticals Inc.'s return since inception?
- Since 2012, Supernus Pharmaceuticals Inc. (SUPN) has compounded at about +15.1% a year — +667.8% in total.